Topical Sirolimus 2%
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Topical Sirolimus 2%, covering 2017-10-24 to 2020-01-30. Get the full timeline:
Most recent: Clinical Trial Update: Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study [Phase 2]